NASDAQ:AMPH | Buybacks | Amphastar Pharmaceuticals, Inc.

AMPH Buybacks

24 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–24; provenance stays internal.

Issuer profilePeriod endTypeReported cash
Amphastar Pharmaceuticals, Inc.2026-03-31Reported repurchase cash$29.49M
Amphastar Pharmaceuticals, Inc.2025-12-31Reported repurchase cash$20.52M
Amphastar Pharmaceuticals, Inc.2025-03-31Reported repurchase cash$11M
Amphastar Pharmaceuticals, Inc.2024-12-31Reported repurchase cash$42M
Amphastar Pharmaceuticals, Inc.2023-12-31Reported repurchase cash$0.00
Amphastar Pharmaceuticals, Inc.2023-03-31Reported repurchase cash$8.02M
Amphastar Pharmaceuticals, Inc.2022-12-31Reported repurchase cash$18.07M
Amphastar Pharmaceuticals, Inc.2022-03-31Reported repurchase cash$1.23M
Amphastar Pharmaceuticals, Inc.2021-12-31Reported repurchase cash$13.44M
Amphastar Pharmaceuticals, Inc.2021-03-31Reported repurchase cash$3.78M
Amphastar Pharmaceuticals, Inc.2020-12-31Reported repurchase cash$3.39M
Amphastar Pharmaceuticals, Inc.2020-03-31Reported repurchase cash$10.95M
Amphastar Pharmaceuticals, Inc.2019-12-31Reported repurchase cash$13.78M
Amphastar Pharmaceuticals, Inc.2019-03-31Reported repurchase cash$3.02M
Amphastar Pharmaceuticals, Inc.2018-12-31Reported repurchase cash$2.61M
Amphastar Pharmaceuticals, Inc.2018-03-31Reported repurchase cash$7.62M
Amphastar Pharmaceuticals, Inc.2017-12-31Reported repurchase cash$5.97M
Amphastar Pharmaceuticals, Inc.2017-03-31Reported repurchase cash$8.2M
Amphastar Pharmaceuticals, Inc.2016-12-31Reported repurchase cash$922,000.00
Amphastar Pharmaceuticals, Inc.2016-03-31Reported repurchase cash$4.72M
Amphastar Pharmaceuticals, Inc.2015-12-31Reported repurchase cash$4.18M
Amphastar Pharmaceuticals, Inc.2015-03-31Reported repurchase cash$1.49M
Amphastar Pharmaceuticals, Inc.2014-12-31Reported repurchase cash-$140,000.00
Amphastar Pharmaceuticals, Inc.2013-12-31Reported repurchase cash$184,000.00